MRNA insider transaction filings
Moderna, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-07. Screen MRNA transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-07 | 4 | Bancel Stephane — Chief Executive Officer, Director | Option exercise (M): 499,246 @ $19.15 · Sale (S): 147,473 @ $56.21 · Sale (S): 124,838 @ $56.96 · Sale (S): 39,891 @ $58.12 · Sale (S): 187,044 @ $58.79 · Option exercise (M): 252,469 @ $19.15 · +4 more | EDGAR |
| 2026-07-16 | 4 | Hoge Stephen — President | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $67.60 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-07-10 | 4 | McDonnell Michael R. — Director | Grant/award (A): 7,415 (derivative) @ $0 · Grant/award (A): 1,618 (derivative) @ $0 · Grant/award (A): 5,733 (derivative) @ $0 | EDGAR |
| 2026-07-07 | 4 | Banque Soria Ester — Chief Commercial Officer | Grant/award (A): 18,658 (derivative) @ $0 · Grant/award (A): 38,364 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 1,452 · Tax withholding (F): 703 @ $72.50 · Option exercise (M): 1,452 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Hoge Stephen — President | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $51.37 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 3,471 @ $30.96 · Sale (S): 3,471 @ $50 · Option exercise (M): 11,798 · Tax withholding (F): 5,705 @ $51.59 · Option exercise (M): 3,471 (derivative) @ $0 · Option exercise (M): 11,798 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 11,798 · Tax withholding (F): 5,705 @ $51.59 · Option exercise (M): 11,798 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 2,475 · Tax withholding (F): 1,197 @ $47.19 · Option exercise (M): 2,475 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 2,165 · Tax withholding (F): 1,047 @ $47.19 · Option exercise (M): 2,165 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | Hoge Stephen — President | Option exercise (M): 9,282 · Tax withholding (F): 4,488 @ $47.19 · Option exercise (M): 9,282 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 773 · Tax withholding (F): 374 @ $47.03 · Option exercise (M): 328 · Tax withholding (F): 159 @ $47.61 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 328 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 773 · Tax withholding (F): 374 @ $47.03 · Option exercise (M): 328 · Tax withholding (F): 159 @ $47.61 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 328 (derivative) @ $0 | EDGAR |
| 2026-05-29 | 4 | Hoge Stephen — President | Option exercise (M): 1,437 · Tax withholding (F): 695 @ $47.03 · Option exercise (M): 610 · Tax withholding (F): 295 @ $47.61 · Option exercise (M): 1,437 (derivative) @ $0 · Option exercise (M): 610 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | AFEYAN NOUBAR — Director | Option exercise (M): 9,263 @ $19.15 · Sale (S): 9,263 @ $46.84 · Option exercise (M): 9,263 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Hoge Stephen — President | Option exercise (M): 37,226 @ $19.15 · Option exercise (M): 16,110 @ $19.15 · Sale (S): 53,336 @ $48.40 · Option exercise (M): 37,226 (derivative) @ $0 · Option exercise (M): 16,110 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Hussain Abbas — Director | Grant/award (A): 8,371 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Horning Sandra — Director | Grant/award (A): 9,681 (derivative) @ $0 · Grant/award (A): 2,092 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | NABEL ELIZABETH G — Director | Grant/award (A): 8,371 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Rubenstein David M. — Director | Grant/award (A): 9,681 (derivative) @ $0 · Grant/award (A): 2,092 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Nader Francois — Director | Grant/award (A): 6,454 (derivative) @ $0 · Grant/award (A): 4,185 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | AFEYAN NOUBAR — Director | Grant/award (A): 12,908 (derivative) @ $0 | EDGAR |
| 2026-05-08 | 4 | Tallett Elizabeth E — Director | Grant/award (A): 8,371 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Hussain Abbas — Director | Option exercise (M): 16,233 · Sale (S): 5,682 @ $46.63 · Option exercise (M): 16,233 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Horning Sandra — Director | Option exercise (M): 16,233 · Option exercise (M): 16,233 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | NABEL ELIZABETH G — Director | Option exercise (M): 16,233 · Option exercise (M): 16,233 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Rubenstein David M. — Director | Option exercise (M): 8,116 · Option exercise (M): 8,116 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Nader Francois — Director | Option exercise (M): 12,174 · Option exercise (M): 12,174 (derivative) @ $0 | EDGAR |
| 2026-05-04 | 4 | Tallett Elizabeth E — Director | Option exercise (M): 4,058 · Option exercise (M): 4,058 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 1,453 · Tax withholding (F): 703 @ $50.03 · Option exercise (M): 1,453 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 11,797 · Tax withholding (F): 5,704 @ $57.80 · Option exercise (M): 11,797 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 11,797 · Tax withholding (F): 5,704 @ $57.80 · Option exercise (M): 11,797 (derivative) @ $0 | EDGAR |
| 2026-03-03 | 4 | Hoge Stephen — President | Option exercise (M): 652 · Tax withholding (F): 316 @ $51.71 · Option exercise (M): 611 · Tax withholding (F): 296 @ $51.71 · Option exercise (M): 1,436 · Tax withholding (F): 695 @ $51.71 · +8 more | EDGAR |
| 2026-03-03 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 233 · Tax withholding (F): 113 @ $51.71 · Option exercise (M): 329 · Tax withholding (F): 160 @ $51.71 · Option exercise (M): 774 · Tax withholding (F): 375 @ $51.71 · +11 more | EDGAR |
| 2026-03-03 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 329 · Tax withholding (F): 160 @ $51.71 · Option exercise (M): 774 · Tax withholding (F): 375 @ $51.71 · Option exercise (M): 9,901 · Tax withholding (F): 4,788 @ $51.71 · +5 more | EDGAR |
| 2026-03-03 | 4 | Bancel Stephane — Chief Executive Officer, Director | Grant/award (A): 250,932 (derivative) @ $0 | EDGAR |
| 2026-02-25 | 4 | Hoge Stephen — President | Option exercise (M): 111,679 @ $19.15 · Option exercise (M): 48,330 @ $19.15 · Sale (S): 160,009 @ $48.84 · Option exercise (M): 111,679 (derivative) @ $0 · Option exercise (M): 48,330 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Mock James M — Chief Financial Officer | Grant/award (A): 2,630 @ $0 · Tax withholding (F): 1,278 @ $41.99 | EDGAR |
| 2026-02-13 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Grant/award (A): 2,630 @ $0 · Tax withholding (F): 1,334 @ $41.99 | EDGAR |
| 2026-02-13 | 4 | Hoge Stephen — President | Grant/award (A): 4,884 @ $0 · Tax withholding (F): 2,362 @ $41.99 | EDGAR |
| 2026-02-13 | 4 | Bancel Stephane — Chief Executive Officer, Director | Grant/award (A): 11,271 @ $0 · Tax withholding (F): 5,450 @ $41.99 | EDGAR |
| 2026-01-06 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 1,452 · Tax withholding (F): 780 @ $30.86 · Option exercise (M): 1,452 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | Bancel Stephane — Chief Executive Officer, Director | Option exercise (M): 688,073 @ $10.90 · Option exercise (M): 688,073 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | AFEYAN NOUBAR — Director | Option exercise (M): 23,853 @ $10.90 · Sale (S): 23,853 @ $29.48 · Option exercise (M): 23,853 (derivative) @ $0 | EDGAR |
| 2025-12-11 | 4 | Hussain Abbas — Director | Sale (S): 504 @ $27.60 | EDGAR |
| 2025-12-08 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 47,190 · Tax withholding (F): 22,817 @ $25.49 · Option exercise (M): 47,190 (derivative) @ $0 | EDGAR |
| 2025-12-08 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 47,190 · Tax withholding (F): 22,817 @ $25.49 · Option exercise (M): 47,190 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Klinger Shannon Thyme — Chief Legal Officer | Option exercise (M): 233 · Tax withholding (F): 113 @ $25.98 · Option exercise (M): 233 (derivative) @ $0 | EDGAR |
| 2025-12-02 | 4 | Hoge Stephen — President | Option exercise (M): 652 · Tax withholding (F): 316 @ $25.98 · Option exercise (M): 652 (derivative) @ $0 | EDGAR |
| 2025-12-01 | 4 | Mock James M — Chief Financial Officer | Option exercise (M): 773 · Tax withholding (F): 374 @ $24.75 · Option exercise (M): 329 · Tax withholding (F): 160 @ $25.01 · Option exercise (M): 773 (derivative) @ $0 · Option exercise (M): 329 (derivative) @ $0 | EDGAR |
Recent 8-K events — Moderna, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-05 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-02-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-11 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-05 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MRNA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →